Article

Be aware of post-surgical diplopia risk

A careful history taking-with special attention to risk factors-may aid ophthalmologists in the prevention of diplopia after surgical procedures, said Anya Trumler, MD.

 

Baltimore-A careful history taking-with special attention to risk factors-may aid ophthalmologists in the prevention of diplopia after surgical procedures, said Anya Trumler, MD.

“Diplopia is a disabling complication of any ocular surgery and should be included in the surgical consent, especially in those at risk,” said Dr. Trumler, assistant professor of ophthalmology, division of pediatric ophthalmology and adult strabismus at The Krieger Children’s Eye Center, The Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore. “It is important for the surgeon to understand the risk factors and mechanism to prevent diplopia complications.”

Of the 1.6 million cataract surgeries performed in the United States each year, the incidence of complications ranges from 0.1% to 6.8%.  These complications can include endophthalmitis, retinal detachment, and cystoid macular edema.

The causes of diplopia may be mechanical, neuromuscular, nerve related, disorder- or toxin-induced, and can include fixation switch, concurrent onset of systemic illness, and tilting of the IOL.

One of the possible causes of diplopia after surgery is the nerve block, Dr. Trumler said.

The reasons for this are unknown, she said, but are hypothesized to include needle injury to the muscle, possible ischemia caused by injection in a perimuscular space causing compression, and neurogenic injury.

“All anesthetic agents directly injected into muscle are myotoxic,” Dr. Trumler said. “Bupivacaine is the most, and procaine the least.”

Treatment includes observation, Fresnel and ground in prisms, and strabismus surgery, she said.

Diplopia is also a well-known complication of scleral buckling for retinal detachment, Dr. Trumler said, and occurs after pars plana vitrectomy without scleral buckle.

Factors that predispose these patients include underlying strabismus, disinsertion of EOM with faulty repositioning, cryotherapy, and multiple reoperations.

The types of diplopia that occur in these patients include hypertropia (58%), horizontal deviation (17%), and torsional (46%).

Aniseikonia from macular disease may cause a separation or compression of photoceptions, or rivalry between central and peripheral fusion. Dragged-fovea diplopia may result from rivalry between central and peripheral fusion as well.

“One treatment option is removal of the scleral buckle,” she said. “(But) wait at least 6 months before doing so.”

Exoplant removal, however, has minimal effects on improving strabismus, and the re-detachment rate ranges from 4% to 33% for various reasons, Dr. Trumler said.

In addition, there seems to have been an increase in the incidence of diplopia related to amniotic graft syndrome, she said.

The increase may be due to several factors, including changes in techniques, more frequent surgical intervention for cosmesis, and more aggressive excision with conjunctival autografts.

Prevention of recurrence includes intraoperative steroid use and avoidance of fibrin blue.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.